Real-world safety and healthcare resource utilization (HCRU) of lurbinectedin (lurbi) in patients (pts) with small cell lung cancer (SCLC): Jazz EMERGE 402 updated analysis.

被引：0
|
作者：
Badin, Firas Benyamine
Lammers, Philip Edward
Patel, Mehul P.
Shunyakov, Leonid
Slater, Dennis
Labbe, Catherine
Naveh, Navit
Boccuti, Anne
Hanvesakul, Raj
Li, Wenyan
Rengarajan, Badri
Halmos, Balazs
机构：
[1] Baptist Hlth Med Grp, Lexington, KY USA
[2] Baptist Canc Ctr, Memphis, TN USA
[3] Rochester Reg Hlth, Rochester, NY USA
[4] Carrie J Babb Canc Ctr, Bolivar, MO USA
[5] Eastern Connecticut Hematol & Oncol Associates, Norwich, CT USA
[6] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada
[7] Jazz Pharmaceut, Philadelphia, PA USA
[8] Jazz Pharmaceut, Oxford, England
[9] Jazz Pharmaceut, Palo Alto, CA USA
[10] Montefiore Einstein Comprehens Canc Ctr, Bronx, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23266
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-World Use of Lurbinectedin in Patients with Small Cell Lung Cancer: Jazz EMERGE 402 Updated Analysis
    Halmos, Balazs
    Lammers, Philip
    Pate, Mehul
    Shapira, Juliana
    Shunyakov, Leonid
    Slater, Dennis
    Labbe, Catherine
    Naveh, Navit
    Boccuti, Anne
    Hanvesaku, Raj
    Li, Wenyan
    Rengarajan, Badri
    Badin, Firas
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E52 - E52
  • [2] EMERGE 402: Real-world Characteristics and Safety of Lurbinectedin in Small-cell Lung Cancer (SCLC)
    Schreeder, D.
    Badin, F.
    Dakhil, S.
    Lammers, P.
    Patel, M.
    Slater, D.
    Migas, J.
    Naveh, N.
    Boccuti, A.
    Hanvesakul, R.
    Li, W.
    Halmos, B.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E43 - E43
  • [3] Efficacy and Safety of Lurbinectedin for Small Cell Lung Cancer in a Real-World Setting: Jazz EMERGE 402 Study
    Halmos, B.
    Lammers, P.
    Liu, G.
    Shunyakov, L.
    Madden, S.
    Kassam, S.
    Patel, M.
    Ji, Y.
    Labbe, C.
    Naveh, N.
    Ndibmun, C.
    Li, W.
    Rengarajan, B.
    Badin, F.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S210 - S211
  • [4] Real-world Safety and Dosing of Lurbinectedin-Treated Patients with Small Cell Lung Cancer: Jazz EMERGE 402 Preliminary Analysis
    Halmos, B.
    Lammers, P.
    Patel, M.
    Shapira, I.
    Shunyakov, L.
    Slater, D.
    Labbe, C.
    Naveh, N.
    Boccuti, A.
    Hanvesakul, R.
    Li, W.
    Rengarajan, B.
    Badin, F.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S381 - S381
  • [5] EMERGE 402: Preliminary Real-world Characteristics and Safety of Lurbinectedin in Patients With Small-cell Lung Cancer
    Bushunow, P.
    Dakhil, S.
    Lammers, P.
    Naveh, N.
    Boccuti, A.
    Hanvesakul, R.
    Li, W.
    Migas, J.
    Slater, D.
    Badin, F.
    Halmos, B.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S145 - S146
  • [6] REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION (HCRU) AND HEALTHCARE COSTS (HCC) OF PATIENTS WITH SMALL-CELL LUNG CANCER (SCLC) IN THE US
    Suri, G.
    Aslam, S.
    Takundwa, R.
    Giannopoulou, M.
    VALUE IN HEALTH, 2024, 27 (06) : S149 - S149
  • [7] REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION (HCRU) AND CLINICAL OUTCOMES OF PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG CANCER (ES-SCLC) IN ALBERTA, CANADA
    Suri, G.
    Boyne, D. J.
    Caveen, M.
    Mak, D.
    Takundwa, R.
    Wani, R. J.
    Cheung, W.
    VALUE IN HEALTH, 2024, 27 (06) : S23 - S23
  • [8] Real-world burden of myelosuppression in patients with small cell lung cancer (SCLC): Retrospective, longitudinal data analysis.
    Epstein, Robert S.
    Krenitsky, JoAnn
    Weerasinghe, Roshanthi K.
    Parrish, Amy S.
    Sanborn, Rachel E.
    Salimi, Tehseen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Efficacy and safety of lurbinectedin in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter, retrospective real-world study
    Xiang, Y.
    Tang, Y.
    Luan, T.
    Mengchen, L.
    Shi, W.
    Chin, A. G. W.
    Feng, X.
    Wang, F.
    Sun, X. W.
    Bao, Z.
    Zhou, J.
    Zhao, J.
    Wu, H.
    Fu, D.
    ANNALS OF ONCOLOGY, 2024, 35 : S1666 - S1667
  • [10] Real-world (RW) outcomes of second-line (2L) small cell lung cancer (SCLC) patients treated with lurbinectedin
    Estrin, A.
    Wang, X.
    Boccuti, A.
    Prince, P.
    Gautam, N.
    Rengarajan, B.
    Li, W.
    Lu, T.
    Cao, Y.
    Naveh, N.
    D'Agostino, R.
    Ben-Joseph, R.
    Ganti, A. K.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1250 - S1250
12345